Postpartum uterine hemorrhage device
The uterine hemorrhage prevention device uses a vacuum source and sealant to control postpartum hemorrhage by inducing uterine contractions and reducing blood loss, addressing maternal mortality from postpartum hemorrhage.
Patent Information
- Application Number
- JP2024148228
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-06-13
- Filing Date
- 2024-08-30
- Publication Date
- 2024-12-03
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Postpartum hemorrhage, particularly due to uterine atony, is a leading cause of maternal mortality, necessitating a rapid and effective method to induce uterine contractions and control excessive bleeding.
A uterine hemorrhage prevention device with an elongate body, flexible loop, shield, and inflatable seal, connected to a vacuum source, creates a vacuum within the uterus to deflate it and promote contractions, using a sealant to maintain the vacuum and remove blood and clots.
The device effectively reduces blood loss by inducing uterine contractions, potentially eliminating the need for blood transfusions and hysterectomies, and can monitor bleeding through integrated collection systems.
Smart Images

Figure 2024167344000001_ABST
Abstract
Description
[Technical field]
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to U.S. Provisional Patent Application No. 62 / 861,233, entitled "Postpartum Uterine Hemorrhage Device," filed on June 13, 2019, the entire contents of which are incorporated herein by reference. This application also claims priority to U.S. Provisional Patent Application No. 62 / 777,642, entitled "Postpartum Uterine Hemorrhage Device," filed on December 10, 2018, the entire contents of which are incorporated herein by reference.
[0002] This application may also be related to U.S. Patent Application Publication No. 2019 / 083132, filed July 13, 2018, entitled "Uterine Hemorrhage Controlling System and Method," the entire contents of which are incorporated herein by reference.
[0003] This application may also be related to U.S. Patent Application Publication No. 2018 / 0055523, filed Aug. 22, 2017, entitled "Uterine Hemorrhage Controlling System and Method," the entire contents of which are incorporated herein by reference. Literature citations
[0004] All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference. [Background technology]
[0005] Postpartum hemorrhage, defined as excessive blood loss after delivery, is the leading cause of maternal mortality worldwide, resulting in the deaths of over 125,000 mothers annually. If uncontrolled, postpartum hemorrhage may require multiple blood transfusions and, in severe cases, may result in death unless the uterus is completely removed. It is therefore desirable to control such postpartum hemorrhage at the onset of symptoms, if possible. The cause of postpartum hemorrhage in approximately 80% of cases is uterine atony, which is the inability of the uterus to contract after delivery. Risk factors for uterine atony include prolonged labor, preeclampsia, and having multiple births. There is therefore a need for a system that can rapidly induce uterine contractions to reduce or completely stop uterine bleeding. Summary of the Invention [Problem to be solved by the invention]
[0006] The present invention has been made to solve the problems in the conventional techniques described above. [Means for solving the problem]
[0007] In general, in one embodiment, a bleeding prevention device includes an elongate body, a flexible looped portion, a shield, and an inflatable seal. The elongate body is configured to be connected to a vacuum source. The flexible looped portion is attached to the elongate body and includes a plurality of holes on an inner circumference thereof. The flexible looped portion is configured to be disposed within a uterus. Activation of the vacuum source is configured to draw a vacuum through the plurality of holes to collapse the uterus when the elongate body is inserted into the uterus. The shield has an edge that folds around an outer circumference of the looped portion and extends radially inward relative to the flexible looped distal portion. The shield is configured to prevent tissue from blocking the plurality of holes when a vacuum is applied. The inflatable seal is attached to the elongate body and configured to seal the uterus.
[0008] This and other embodiments may include one or more of the following features: The flexible looped portion may be configured to collapse upon delivery and self-expand into an inflated loop shape. The shield may extend around 270-320° of the circumference of the flexible looped distal portion. The shield may extend radially inward a distance of 0.02-0.020". The plurality of holes may include 10-20 holes. The sealant may include a disc-shaped central portion and tapered proximal and distal ends. The device may further include a valved port in fluid communication with the elongate body. The valved portion may be configured to provide inflation fluid to the inflatable sealant. The valve may include a check valve.
[0009] In general, in one embodiment, a bleeding prevention device includes a first elongated tube, a second elongated tube, a connector, and a plurality of holes. The first elongated tube has a first central channel. The second elongated tube has a second central channel and is joined to and parallel to the first elongated tube, thereby forming an axial valley between the first elongated tube and the second elongated tube. The connector is configured to connect the first and second central channels to a vacuum source. The plurality of holes are disposed along the valley. Each of the plurality of holes extends from an outer surface of the device and communicates with both the first and second central channels. Activation of the vacuum source is configured to draw a vacuum through the plurality of holes to deflate the uterus when the device is inserted into the uterus.
[0010] This and other embodiments may include one or more of the following features: Each of the plurality of holes may include an elongated shape along the valley. Each of the plurality of holes may include a circular shape along the valley. The bleeding prevention device may further include a sealant disposed along the first and second elongated tubes. The sealant may have a disk-shaped central portion and tapered proximal and distal ends. The valleys may be 0.02-0.20" deep. The valley angle may be 10-80 degrees. The ratio of device width to device height may be 1.4-2.3, wherein the width and height are perpendicular to the axial valleys. The ratio of device height to device width may be 1.4-2.3, wherein the width and height are perpendicular to the axial valleys. The ratio of device height to device width may be about 1, wherein the width and height are perpendicular to the axial valleys. Each of the plurality of holes may extend completely through the valleys from the outer surface to the opposite second outer surface. The bleeding prevention device may further include a tapered distal tip.
[0011] In general, in one embodiment, a bleeding prevention device includes an elongate body and a sealant. The elongate body is configured to be connected to a vacuum source and has a plurality of holes. Activation of the vacuum source is configured to draw a vacuum through the plurality of holes to collapse the uterus when the elongate body is inserted into the uterus. The sealant is attached to the elongate body and configured to seal the uterus. The sealant includes a proximal ring and a distal skirt and is configured to have a generally conical shape.
[0012] This and other embodiments may include one or more of the following features: The sealant may be proximal to the hole. The angle of the skirt relative to the elongate body may be between 30 and 60 degrees. The ring may be between 2 and 10 mm in diameter. The ring may be stiffer than the skirt. The ring may be thicker than the skirt. The skirt may be between 1 and 1.5 mm in thickness. The ring may be in a plane that is approximately perpendicular to the longitudinal axis of the elongate body. The proximal ring may be configured to press against tissue of the vaginal canal or cervical wall. The sealant may be configured to evert when the elongate body is pulled proximally. The skirt may connect to an outermost diameter portion of the proximal ring when the sealant is everted. The thickness of the skirt may vary from its proximal end to its distal end. The thickness of the skirt may be uniform from its proximal end to its distal end.
[0013] The novel features of the invention are set forth with particularity in the claims which follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and by reference to the accompanying drawings, in which: [Brief description of the drawings]
[0014] [Figure 1A] 1 illustrates an exemplary system for controlling uterine bleeding. [Figure 1B] 1 illustrates another exemplary system for controlling uterine bleeding. [Figure 2A] FIG. 1 is a side perspective view of an exemplary insertable device for controlling uterine bleeding. [Figure 2B] FIG. 2B is another side perspective view of the insertable instrument of FIG. 2A. [Figure 2C] FIG. 2B is another side perspective view of the insertable instrument of FIG. 2A. [Figure 2D] FIG. 2B is a perspective view of a shield of the insertable instrument of FIG. 2A. [Figure 2E] FIG. 2B is a cross-sectional view of the shield of the insertable instrument of FIG. 2A. [Figure 2F] FIG. 2B is a detailed view of the shield of the insertable instrument of FIG. 2A. [Figure 2G]FIG. 2B is a development of the inner circumference of the loop portion of the insertable device of FIG. 2A. [Figure 2H] FIG. 2B is a side view of the encapsulant of the insertable instrument of FIG. 2A. [Figure 2I] FIG. 2B is a cross-sectional view of the proximal end of the insertable instrument of FIG. 2A. [Diagram 3] FIG. 1 is a perspective view of another exemplary insertable device for controlling uterine bleeding. [Figure 4] FIG. 1 is a perspective view of another exemplary insertable device for controlling uterine bleeding. [Diagram 5] FIG. 1 is a perspective view of another exemplary insertable device for controlling uterine bleeding. [Figure 6A] 1 is a cross-sectional view of another device for controlling uterine bleeding. [Figure 6B] FIG. 6B shows a side view of the insertable device of FIG. 6A. [Figure 7] 1 is a cross-sectional view of another device for controlling uterine bleeding. [Figure 8] 1 is a cross-sectional view of another device for controlling uterine bleeding. [Figure 9] 1 is a cross-sectional view of another device for controlling uterine bleeding. [Figure 10] 1 is a cross-sectional view of another device for controlling uterine bleeding. [Figure 11] 1 is a cross-sectional view of another device for controlling uterine bleeding. [Figure 12A] FIG. 1 is a perspective view of another exemplary insertable device for controlling uterine bleeding. [Figure 12B] FIG. 12B is a cross-sectional view of the insertable instrument of FIG. 12A. [Figure 13A] FIG. 1 is a perspective view of another exemplary insertable device for controlling uterine bleeding. [Figure 13B] FIG. 13B is a cross-sectional view of the insertable instrument of FIG. 13A. [Figure 13C] 1A-1D are perspective views of several different insertable devices for controlling uterine bleeding. [Figure 14] 1 shows an exemplary distal tip of an insertable device for controlling uterine bleeding. [Figure 15A] 13 illustrates another exemplary distal tip of an insertable device for controlling uterine bleeding. [Figure 15B]15B shows the distal tip of FIG. 15A being pressed against tissue. [Figure 16] FIG. 13 is a side view of another exemplary insertable device for controlling uterine bleeding. [Figure 17A] 1 illustrates a foam sealant of one exemplary insertable device for controlling uterine bleeding. [Figure 17B] 17B shows the foam encapsulant of FIG. 17A in a compressed configuration. [Figure 18] FIG. 13 is a side view of another exemplary sealant for use in an insertable device to control uterine bleeding. [Figure 19] FIG. 13 is a side view of another exemplary sealant for use in an insertable device to control uterine bleeding. [Figure 20] FIG. 13 is a top view of another exemplary sealant for use in an insertable device for controlling uterine bleeding. [Figure 21] FIG. 13 is a side perspective view of another exemplary sealant for use in an insertable device for controlling uterine bleeding. [Figure 22] FIG. 13 is a side perspective view of another exemplary sealant for use in an insertable device for controlling uterine bleeding. [Figure 23A] FIG. 13 is a side perspective view of another exemplary sealant for use in an insertable device for controlling uterine bleeding. [Figure 23B] FIG. 23B is a side perspective view of the encapsulant of FIG. 23A having a helical ridge or valley. [Figure 24] FIG. 13 is a side perspective view of another exemplary sealant for use in an insertable device for controlling uterine bleeding. [Diagram 25] FIG. 13 is a side perspective view of another exemplary sealant for use in an insertable device for controlling uterine bleeding. [Figure 26A] FIG. 13 is a side perspective view of another exemplary sealant for use in an insertable device for controlling uterine bleeding. [Figure 26B] FIG. 26B is a side perspective view of the sealant of FIG. 26A with the distal end rolled in the proximal direction. [Figure 27] FIG. 13 is a side perspective cross-sectional view of another exemplary sealant for use in an insertable device for controlling uterine bleeding. [Figure 28] 13A-13C are cross-sectional views of another exemplary sealant for use in an insertable device for controlling uterine bleeding. [Figure 29] 13A-13C are cross-sectional views of another exemplary sealant for use in an insertable device for controlling uterine bleeding. [Figure 30A] 1 is a cross-sectional view of another exemplary insertable device for controlling uterine bleeding. [Figure 30B] 30B illustrates the insertion of the insertable instrument of FIG. 30A. [Figure 30C] 30B shows the insertable device of FIG. 30A inverted. [Figure 30D] 30B illustrates the inversion of the insertable instrument of FIG. 30A when the shaft is pulled proximally. [Diagram 31] 1 is a cross-sectional view of another exemplary insertable device for controlling uterine bleeding. [Diagram 32] 1 shows the distal portion of an insertable device for controlling uterine bleeding folded over. [Diagram 33] 1 illustrates an exemplary placement of an insertable device within the body to control uterine bleeding. [Diagram 34] 1 shows a syringe used to introduce inflation fluid into an insertable device for controlling uterine bleeding. [Diagram 35] 1 shows an exemplary connection tube for an insertable device for controlling uterine bleeding. [Diagram 36] 12A-12B show the valley depth and angle of the device. [Figure 37] 13A-13B show the valley depth and angle of the device. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0015] Described herein are uterine bleeding devices, systems, and methods that create a vacuum within the uterine space after birth while drawing blood and / or clots from the uterine space. The vacuum can advantageously promote a physical collapse of the uterine space, which in turn induces trends within the uterus that act to control bleeding.
[0016] FIG. 1A illustrates an exemplary system 100 for inhibiting uterine bleeding, according to one embodiment. The system 100 functions to reduce or completely stop uterine bleeding that may occur if a woman develops uterine atony after delivery, in which the uterus does not contract. Inhibiting uterine bleeding may substantially reduce the total amount of blood loss from the uterus and may reduce the need for blood transfusions or hysterectomies for the woman. In the embodiment of FIG. 1A, the system 100 promotes uterine contractions by sealing an opening to the uterus and varying the pressure within the uterus. The change in pressure creates a vacuum within the uterus, which provides a uniform mechanical stimulation to the uterine wall, promoting tissue tamponade and contractile movement. In the embodiment of FIG. 1A, the system 100 includes an insertable instrument 105, a pump 110, and a collection container 115.
[0017] The insertable instrument 105 is configured to be inserted into the uterus and transmit pressure changes provided by the pump 110. In the embodiment of FIG. 1A, the insertable instrument 105 is delivered transvaginally (through the vagina), with the distal portion 120 of the insertable instrument 105 positioned within the uterus and the proximal portion 125 of the insertable instrument 105 remaining outside the uterus. The distal portion 120 may be of a flexible structure and conforms to the anatomical structure of the uterus. A sealant 122 between the distal portion 120 and the proximal portion 125 can form a seal at the opening of the uterus. The proximal portion 125 of the insertable instrument 105 is coupled to the pump 110. FIG. 33 illustrates an exemplary placement of the sealant 122 at the opening of the cervix 186 in the vaginal canal 189, with the distal portion 120 located within the uterus 188. In some embodiments, the insertable device 105 may have a sheath that facilitates insertion of the insertable device 105 into the uterus and can also prevent airflow from the pump 110 being directed to the uterus prematurely.
[0018] The pump 110 generates a pressure change that creates a vacuum within the uterus. In the embodiment of FIG. 1A, the pump 110 is coupled to the proximal portion 125 of the insertable instrument 105. In some embodiments, a connecting tube 130 is attached to the proximal portion 125 and the pump 110, thereby coupling the pump 110 and the insertable instrument 105. In some embodiments, a collection chamber 115 is located along the connecting tube 130 between the pump 110 and the proximal portion 125 to prevent blood from entering the pump 110, as described in more detail below. In some embodiments, the connecting tube 130 includes a directional control valve that allows fluid to flow in one direction and prevents fluid from flowing in the reverse direction. An exemplary connecting tube 130 is shown in FIG. 35. A connector 147 of the tube 130 is configured to mate with a connector 148 of the insertable instrument 105.
[0019] When activated, the pump 110 generates an air flow that is directed through the channels and / or openings of the insertable instrument 105 to the uterus. Generally, the vacuum pump is configured to remove molecules from the sealed space leaving behind a partial vacuum. Because the uterus is sealed (e.g., by the sealant 122) once the instrument 105 is in place, the air flow by the pump 110 reduces the pressure within the uterus, which reduces the pressure within the uterus below atmospheric pressure outside the uterus (e.g., less than 1 atmosphere). This vacuum ensures that the air flow travels unidirectionally from the uterus through the insertable instrument 105 to the pump 110. In some embodiments, the pump 110 may be configured to provide a vacuum pressure of 60-150 mmHg (e.g., 70-90 mmHg, e.g., about 80 mmHg). The vacuum within the uterus provides a uniform mechanical stimulation to the uterine wall, promoting tamponade, arterial vasoconstriction, and contractile movement of the uterine wall. Additionally, the vacuum created allows for the removal of biological material within the uterus. The biological material may include blood, tissue, etc. Pump 110 may be powered (automatic) or manually operated. In embodiments in which pump 110 is manually operated, pump 110 may be capable of generating a vacuum within the uterus in a first state and of drawing biological material into collection container 115 while maintaining the vacuum within the uterus in a second state.
[0020] The collection reservoir 115 collects biological material removed from the uterus. As shown in FIG. 1A, the collection reservoir 115 may be connected in line with the pump 110. The proximal portion 125 of the insertable instrument 105 is connected to the collection reservoir 115 and the pump 110 by a connecting tube 130. In this embodiment, when the pump 110 is activated, fluid (e.g., air, biological material, etc.) flows through the connecting tube 130 toward the pump 110. The biological material is removed from the connecting tube 130 before reaching the pump 110 and collected in the collection reservoir 115. Collecting biological material from the uterus may allow a user to monitor and measure the amount of blood loss due to uterine bleeding. Monitoring blood loss may further allow a user to determine if, when, and / or to what extent uterine contractions have occurred.
[0021] In some embodiments, the system 100 can be used to prevent postpartum hemorrhage in addition to monitoring and / or treating postpartum hemorrhage. For example, the system 100 can be used to assist in uterine contractions in a woman after delivery. The flexibility of the insertable instrument 105 allows a healthcare provider (e.g., a nurse, physician, surgeon, etc.) to abdominally palpate the woman's uterine tissue to detect if and / or when the uterus has contracted. Additionally, the flexibility of the insertable instrument 105 allows the insertable instrument 105 to be folded and bent for positioning while other vaginal wall or tissue repair surgeries are being performed. FIG. 32 shows the distal portion 120 of the instrument 105 being manually folded in preparation for insertion into the uterus.
[0022] In some embodiments, the insertable instrument 105 may be configured to remain outside the uterus and be inserted into the vaginal canal or cervix (e.g., the upper vaginal canal, the cervical os, or tissue adjacent thereto). The sealant 122 may form a seal between the vaginal or cervical opening and the uterus. By forming a seal, air flow by the pump 110 may reduce the pressure inside the uterus below atmospheric pressure outside the uterus, creating a vacuum within the uterus. As previously discussed, this provides a uniform mechanical stimulation to the uterine wall to promote uterine wall tamponade, arterial vasoconstriction, and contractile movement.
[0023] FIG. 1B illustrates a system 200 for suppressing uterine bleeding according to another embodiment. System 200 is similar to system 100, except that it does not include a separate collection chamber. Thus, system 200 includes an insertable device 105 and a pump 110. A proximal portion 125 of insertable device 105 is connected to pump 110 by a connecting tube 130. In this embodiment, a collection container may be integrated with pump 110, and fluid (e.g., air, biological material, etc.) passes through connecting tube 130 and into pump 110, where the biological material is collected in a separate compartment of pump 110. This compartment that collects the biological material may be detachable from pump 110. This may assist a healthcare provider in monitoring the amount of biological material collected.
[0024] 2A-2I show detailed views of an insertable device 205, another embodiment similar to device 105. Insertable device 205 includes a proximal portion 225, a distal portion 220, and a sealant 222 therebetween.
[0025] The proximal portion 225 includes an elongated body 238 or shaft that houses a vacuum channel 231, a connector 237 for connecting the channel 231 to a pump, an inflation channel 236, and a valved port 239 for introducing inflation medium into the sealant 222 via the inflation channel 236. In some embodiments, the inflation channel 236 and the vacuum channel 231 may extend adjacent and / or parallel to one another. The valve in the valved port 239 may be, for example, a check valve that does not allow fluid flow when a syringe is not engaged and opens to allow fluid flow when a syringe is engaged. FIG. 34 illustrates an example syringe 234 configured to be inserted into the valved port 239 to introduce inflation medium.
[0026] Returning to FIGS. 2A-2I, the distal portion 220 includes a flexible loop portion 223 that collapses when delivered to the uterus and then self-expands to a loop shape that conforms to the uterus. The loop portion 223 further includes an inner loop portion 232 and a shield 233. The inner loop portion 232 is continuous with and fluidly connected to the proximal portion 225. The inner loop portion 232 includes a number of holes 229 on its inner circumference for applying a vacuum through the holes 229 (via a connection with a vacuum channel 231). For example, there may be 10-30 holes 229 (e.g., 20 holes 229). The multiple holes 229 may be useful for providing redundancy in case one or more holes become blocked during use. The shield 233 is capable of conforming to and folding around the outer circumference of the inner loop portion 232. For example, shield 233 may extend around 270-320° of the circumference of inner loop portion 232. Additionally, the edges of shield 233 may extend radially inward from inner loop portion 232 by a distance of 0.02-0.20", e.g., 0.04-0.15", e.g., about 0.08". The overhanging edges of shield 233 may advantageously help protect holes 229 from being blocked by tissue as vacuum is drawn through holes 229.
[0027] The sealant 222 may have a disk-shaped central portion 292 and tapered proximal and distal ends 293a, 293b. The sealant 222 may be, for example, an inflatable balloon that is inflated through a valved port 239. The volume of fluid used to inflate the sealant 222 may be, for example, 30-200cc (e.g., 40-120cc, e.g., about 60cc).
[0028] In some embodiments, the insertable instruments (e.g., used in system 200) may be of a different shape (i.e., not looped) and / or may be used without a separate shield. For example, FIGS. 3-13 show various exemplary insertable instruments. The instruments of FIGS. 3-13 may be designed to allow for aspirating the surrounding fluid (through multiple different holes) while at the same time preventing tissue and large clots from getting close enough to the holes to stop flow with ridges and / or lips. These multiple holes can advantageously prevent the holes from becoming blocked by tissue and / or clots by both allowing redundancy in case some holes become blocked and distributing the vacuum load across the holes. Any of the instruments shown in FIGS. 3-13 may be extruded, for example, from a single material (e.g., a thermoplastic material such as polyurethane). Such a single extrusion can advantageously keep the cost of the design low while providing flexibility and rigidity. In some embodiments, the devices shown in Figures 3-13 may be made of multiple extrusions and / or molded parts of varying durometers that are fused together for optimal design. Forming holes in the extrusions may be done by, for example, drilling, punching, laser, or water jet cutting.
[0029] FIG. 3 illustrates an exemplary insertable instrument 305. The instrument 305 includes an elongated shaft 333 that is generally straight (i.e., not looped). A number of holes 301 extend outwardly from a central vacuum channel 307 in the sidewall of the shaft 333 (i.e., for applying a vacuum through the holes). Wings or ridges 331 extend radially from and along the length of the shaft 333. The ridges 331 are angled relative to one another such that a generally V-shaped groove is formed between the ridges 331 that extends along the length of the shaft 333. The outermost edges of the ridges 331 may be rounded and / or atraumatic to body tissue. In some embodiments, the ridges 331 may be arranged such that four ridges 331 form a generally "X" shaped cross section of the instrument 305, as shown in FIG. 3. Additionally, holes 301 may be located between ridges 331 (e.g., at the bottom or apex of a V-shaped groove), which may help keep holes 301 open for application of vacuum and removal of blood from the uterus by preventing tissue from being drawn into holes 301. Additionally, holes 301 may be located in alternating and / or different positions along the longitudinal axis of shaft 333 (i.e., holes in adjacent grooves may be at different axial positions), which may help both prevent clogging with tissue and maintain stability of device 305.
[0030] 4 illustrates another exemplary insertable instrument 405. Instrument 405, like instrument 305, includes a generally straight shaft 433 with a number of holes 401 extending through its sidewall. Holes 401 are randomly positioned along shaft 433. Additionally, instrument 405 may include ridges on its surface and / or may include raised features around holes 401 to help prevent tissue from blocking holes 401 upon application of vacuum.
[0031] 5 illustrates another exemplary insertable instrument 505. Instrument 505 is similar to instrument 305, but shaft 533 includes only three longitudinal ridges 531 with holes 501 between the ridges 531.
[0032] 11 illustrates another exemplary device 1105 that is similar to device 505, but includes a sharp knife-like edge 1111 extending radially from each ridge 1131. The edges 1111 are curved inwardly to face circumferentially about the device 1105 to aid in cutting through clots as the device 1105 is twisted or rotated (e.g., clockwise in FIG. 11).
[0033] 6A-6B show another exemplary insertable instrument 605. Instrument 605 is similar to instrument 305, except that it includes two parallel ridges 631 a,b on each of the four sides of shaft 633. As shown, each pair of ridges 631 a,b may be positioned approximately 90 degrees apart from an adjacent pair. Holes 601 may extend within shaft 633 between the individual ridges 631 a,b of each pair of parallel ridges 631 a,b. Additionally, in some embodiments (as shown in FIGS. 6A-6B), holes 601 may be through holes, allowing passage from one side of shaft 633 completely through vacuum channel 607 to the other side. However, adjacent holes 601 may be offset longitudinally (as shown in FIG. 6B) to ensure the integrity of instrument 605.
[0034] 7 illustrates another exemplary insertable device 705 that is similar to device 605, except that it includes only three pairs of ridges 731 a, 731 b (each pair positioned approximately 120 degrees apart from an adjacent pair). Holes 701 may be similarly positioned within shaft 733 between the individual ridges 731 a, b of each pair of ridges 731 a, b.
[0035] 8 shows another exemplary insertable instrument 805, which is similar to instrument 605, except that it includes only two pairs of ridges 831 a,b (these pairs are positioned approximately 180 degrees apart from each other). The holes 801 in the shaft 833 between the individual ridges 831 a,b of the pairs of ridges 831 a,b may be through holes that extend from one side of the instrument through a central vacuum channel 807 to the other side. The insertable instrument 805 may be substantially flat since there are only two sets of ridges that are approximately 180 degrees apart from each other. This design may provide enhanced flexibility or pliability in one direction (i.e., the short axis) compared to another direction (i.e., the long axis).
[0036] 9 shows another exemplary insertable instrument 905 that includes a generally straight shaft 933 having a plurality of holes 901 extending from a central vacuum channel 907 within a sidewall of the shaft 933 to the exterior of the shaft 933 (i.e., for applying a vacuum through the holes 901). Protrusions 991 extend radially from the shaft 933 along the length of the shaft 933. The instrument 905 includes four protrusions that are spaced approximately 90 degrees apart from one another. Additionally, the outermost tips of the protrusions 991 may each include a circumferential extension 995 having a crescent-shaped cross-section. The extensions 995 extend circumferentially around the instrument 905 (i.e., for providing the instrument 905 with a substantially circular profile that is atraumatic to human tissue). Open spaces 993 between the extensions 995 and between the protrusions 991 and the extensions 995 can advantageously allow the vacuum to reach the holes 901 while the large circumferential coverage of the extensions 995 can prevent tissue from collapsing over the holes 901. In some embodiments, the extensions 995 can include sharp inner edges 997 that can aid in cutting through the clot by twisting the instrument 905 in a clockwise or counterclockwise direction.
[0037] FIG. 10 shows another exemplary insertable device 1005, which is similar to device 905, except that it includes only three protrusions 1091 (which are positioned, for example, approximately 120 degrees apart from each other).
[0038] Another exemplary insertable instrument 1205 is shown in Figures 12A-12B. The instrument 1205 includes a shaft 1233 that is generally straight and includes two tubular sections 1212a, 1212b that extend side-by-side and parallel. Each tubular section 1212a, b includes a vacuum channel 1207a, b extending therethrough. The junction between the two tubular sections 1212a, b defines a longitudinal valley 1221a, b therebetween in which the bore 1201 may be located (i.e., the bore 1201 is in communication with the two vacuum channels 1207a, b). Locating the bore 1201 within the longitudinal valley 1221a, b may advantageously help to prevent tissue from being drawn into the bore 1201. In some embodiments, the respective diameters d of the vacuum channels 1207a, b may be 0.1 mm or less. v may be 3-6 mm (e.g., 5 mm), and the distance d between the vacuum channels 1207a,b b The diameter of the hole 1201 may be 2 to 5 mm (eg, 3 mm).
[0039] Another exemplary insertable device 1305 is shown in Figures 13A-13C. The device 1305 is similar to the device 1205, except that the tubular section 1312a,b of the shaft 1333 is partially flattened, resulting in elliptical vacuum channels 1307a,b with deeper valleys 1321a,b, and the hole 1301 has an elongated cross section (although of course the cross section of the hole 1301 may be circular as well). In some embodiments (as shown in Figure 13A), the hole 1301 may be a through hole that may extend from one side to the other. The orientation of the elliptical shape may advantageously allow selective bending. For example, referring to Figure 13B, the device 1305 may be inserted into the uterus with a plane defined by the Y direction (i.e., the coronal plane) parallel to the delivery table on which the parturient woman is lying on her back. The direction of preferential flexion / bending is then in the X direction (perpendicular to the coronal plane), which coincides with the anatomical curvature of the uterus.
[0040] 36-37, the valley 1221, 1321 formed between the two tubular members 1212, 1312 of the device 1205, 1305 (or a similar device) has a depth (d c ) and an angle (α) formed by lines intersecting at a vertex at or near the bottom of the valleys 1221, 1321. c is measured from the apex of the angle to the top surface of the tubular member 1212, 1312. If the instrument 1205, 1305 is to be reused, the larger the angle α, the easier it is to clean the valleys 1221, 1321. However, a larger angle α may lead to overlying tissue sagging and blocking holes at the bottom of the valleys 1221, 1321. A smaller angle α may be less likely to cause overlying tissue to sag and block holes, but the narrower the bottom of the valleys 1221, 1321, the more likely it is that the valleys will become filled with blood clots. Furthermore, the narrower the valleys 1221, 1321, the more difficult it may be to clean the instrument 1205, 1305 if it is to be reused. Therefore, the depth d of the valleys 1221, 1321 may be adjusted to reduce the amount of overlying tissue that will sag and block holes. cThe angle α of the valleys 1221 and 1321 may be 10 to 80 degrees (for example, 20 to 65 degrees). c and angle α advantageously allows for proper cleaning of instruments 1205, 1305 while avoiding blockage by blood or loose tissue.
[0041] 13C shows variations (1305a-1305j) of the device 1305. Variations 1305a, 1305b, 1305e, and 1305f are flatter than the other variations (i.e., the thickness in the Y direction is less than the thickness in the X direction), and therefore the holes 1301 extend through a thinner cross section. In contrast, variations 1305c, 1305d, 1305g, and 1305h have holes 1301 extend through a thicker cross section (because the thickness in the Y direction is greater than the thickness in the X direction). By having holes 1301 extend through a thicker cross section (as is the case for variations 1305c, 1305d, 1305g, and 1305h), they can more easily be aligned with the two sides of the approaching uterine surface, thereby facilitating the aspirating of fluid from those two sides. In some embodiments, the ratio of width in the X direction to height in the Y direction (or vice versa) of the device of Figures 13A-13C may be between 1.4 and 2.3, thereby allowing selective bending.
[0042] Any of the insertable instruments of Figures 3-13 may have a tapered and / or atraumatic distal tip to avoid damaging the uterine wall during insertion and use. For example, Figure 14 shows an exemplary distal tip 1461. The distal tip 1461 may be of a diameter equal to or smaller than the diameter of the rest of the insertable instrument (e.g., the shaft of the insertable instrument). Similarly, an exemplary tip 661 is shown in Figure 6B. The tip 661 may have a conical shape where the ridges 631 abut and / or terminate, such that the distal ends of none of the ridges 631 directly contact tissue. As shown in Figures 14 and 6B, in some embodiments, a central vacuum channel 1407, 607 may extend throughout the instrument (including the tips 1461, 661), for example, to provide additional vacuum ports at the distal end and / or to allow for flushing or cleaning of the instrument. 15A-15B, in some embodiments, the tip 1561 can be a soft dome that can collapse during engagement with tissue 1515 so as not to puncture the uterus (as shown collapsing in FIGS. 15A-15B). In some embodiments, the dome tip 1561 can be hollow. In another embodiment, the dome tip 1561 can include a soft sponge-like material or molded webbing therein that provides optimized flexibility or softness for engagement with tissue.
[0043] 16 illustrates another exemplary insertable instrument 1605. The instrument 1605 includes a proximal bulbous structure 1616 and a distal bulbous structure 1618. A hole 1601 (for connecting to a vacuum channel) is located in a valley 1619 formed between the proximal bulbous structure 1616 and the distal bulbous structure 1618. The bulbous structures 1616, 1618 may be made of a soft material (e.g., foam or webbing) that is sufficiently collapsible when inserted through the cervix, yet rigid enough to prevent tissue from blocking the hole 1601 upon application of vacuum.
[0044] A variety of sealant designs are possible for use with the bleeding prevention devices and systems described herein (e.g., systems 100 or 200 and / or systems having any of the instruments shown in Figures 2A-13C). For example, sealant 222 may be used in any of the instruments described herein. In one embodiment, sealant 222 may be disposed along shaft 1333 of instrument 1305. Similarly, Figures 17-30 show several various exemplary sealant designs that may be used in any of the instruments described herein.
[0045] 17A-17B show an insertable device 1705 having a sealant 1722. The sealant 1722 may be made of a thin, highly compliant sheath 1719 with a foam material 1771 therein. A vent hole or slit 1717 may extend through the proximal end of the sheath 1719, allowing air to enter the foam material 1771 and inflate the sealant 1722. As shown in FIG. 17B, the sealant 1722 may be collapsible (by squeezing with the palm or fingers before insertion into the body) and then inflated once inside the body to conform to the anatomy. In some embodiments, the sealant 1722 may be connected to an inflation lumen (e.g., running parallel to the vacuum lumen as described above) to aid in the inflation of the sealant 1722. In another embodiment, exposing slit 1717 at the proximal end of sealant 1722 allows for sufficient air entrapment to eliminate the need for an inflation lumen.
[0046] 18 is a side view of an umbrella-shaped (or cone-shaped) diaphragm seal 1822 with an insertable instrument shaft 1833 extending above the center. The distal curved end (or skirt) 1881 of the diaphragm 1822 is intended to face the uterus (i.e., the narrow end is closest to the uterus), while the proximal ring 1882 can maintain the circular shape of the proximal end. The distal skirt 1881 can seal against the cervical opening, or the outer ring 1882 can seal against tissue of the vaginal canal or cervical canal, thereby creating a vacuum within the uterus. In some embodiments, the outer ring 1882 can press against and / or continuously radially contact tissue of the vaginal canal or cervical wall to maintain a seal within the uterus.
[0047] 30A-30D show an insertable device 3005 similar to the insertable device 1822, which includes an umbrella-shaped (or cone-shaped) diaphragm seal 3022, with the shaft 3033 of the insertable device 3055 extending above the center of the seal 3022. In comparison to the seal 1822, the distal skirt 3081 of the seal 3022 has a smaller angle α with respect to the shaft 3033 (see FIG. 30A) (e.g., angle α may be 30-60 degrees (e.g., about 45 degrees)). The proximal ring 3082 may be a heavy or stiff ring (e.g., a solid polymer ring with a diameter of 2-10 mm (e.g., about 5 mm)). The stiff ring 3082 may advantageously maintain a circular or elliptical shape even when tissue collapses around the ring 3082. The distal skirt 3081 may also be thicker than the skirt of the sealant 1822 (eg, the wall thickness of the skirt 3081 may be 1-1.5 mm, such as about 1.2 mm).
[0048] 30B, when the ring 3082 is inserted into the vaginal or cervical canal, it can be fixed against the vaginal or cervical wall tissue 3031 to seal the device there. The stiffness of the ring 3082 can advantageously help to hold the shape of the ring 3082 in-plane (i.e., in the plane of the plane 3035 perpendicular to the longitudinal axis 3037 of the shaft 3033). The thick skirt 3081 in place and in tension can also help to keep the ring 3082 in place (in the plane of the plane 3035 perpendicular to the longitudinal axis 3037) and prevent the ring 3082 from rotating, rolling over, and / or losing its seal. Anatomically, this design and orientation of the sealant 3022 can advantageously provide an optimal orientation to effect a seal against the vaginal or cervical wall tissue 3031.
[0049] 30C, the skirt 3081 of the insertable instrument 3005 may be configured to invert when the shaft 3033 is pulled in a proximal direction. That is, the flexible skirt 3081 may begin to unwind on itself when a force is applied in a proximal direction, typically beginning with the portion of the skirt closest to the shaft 3033. The tendency to invert (the force required to invert) may depend, for example, on the thickness of the skirt 3081, particularly the thickness of the portion just adjacent to the shaft 3033. Furthermore, the tendency to invert may depend on the angle α between the skirt 3081 and the shaft 3033. The larger the angle α, the easier it is to invert. On the other hand, the smaller the angle α, the more resistant the skirt 3081 is to lying or rotating the face of the ring 3082.
[0050] As shown in FIG. 30D, eversion of the skirt 3081 can form a cone-shaped tip 3091 that parts the vaginal or cervical wall tissue 3031 as it is pulled proximally. Additionally, the attachment of the ring 3082 to the skirt 3081 can be designed to have the smoothest outer surface in the direction of removal to avoid damaging repair sutures 3098 that may be placed in the vaginal or cervical canal. For example, the attachment of the skirt 3081 to the stiff ring 3082 can be at the outermost diameter of the device 3005 when the skirt 3081 is everted, so that as the device 3005 is retracted proximally, the skirt 3081 (at the shallowest angle relative to the vaginal or cervical wall tissue 3031) can easily clear tissue, especially repair sutures 3098, if any, on the vaginal or cervical wall. As the skirt gets longer (while the angle α gets smaller and the diameter of the stiff ring 3082 remains the same), the slope of the skirt against the tissue wall becomes shallower and it becomes easier to overcome the suture 3098.
[0051] Of course, it may be advantageous to maintain a perpendicular relationship between the plane of the ring 3082 and the longitudinal axis of the shaft 3033, but some variation in that perpendicular relationship may also be useful to allow flexibility for various anatomical structures.
[0052] In some embodiments, the thickness of the skirt 3081 may vary from the proximal to the distal end so that the bending pattern of the skirt 3081 is optimized. For example, the thickness may be tailored for specific distances between the attachment to the shaft and the rigid ring. FIG. 31 shows an example insertable instrument 3105 with thinned portions 3187a,b along the length of the skirt 3181. The variation in thickness may be advantageous for instrument placement and operation / sealing, as well as enhancing the eversion mechanism upon removal of the instrument.
[0053] 19 is a side view of the cupping cuff sealant 1922 with the shaft 1933 of the insertable instrument extending above the middle section. The distal ring 1991 faces the uterus and surrounds the outside of the cervical opening and can rest within the vaginal vault. A curved proximal end 1993 can cup the cervical opening to form a seal that holds the vacuum within the uterus.
[0054] 20 is a top view of a foldable sealant 2022 in a partially folded configuration. Sealant 2022 is similar to sealant 1822, except that it includes radial folds 2020 that allow it to easily collapse into an umbrella shape during insertion (i.e., to easily fold into the smaller diameter vaginal or cervical canal), but after insertion, the umbrella shape can expand to fill a larger space and form a sealant that holds the vacuum within the uterus.
[0055] 21 is an isometric view of a seal 2122 surrounding an insertable instrument shaft 2133. The seal 2122 is a flat, disk-shaped seal having multiple connected rings 2114 that allow the disk to telescope into a conical shape. In use, the outermost ring 2114 may trap vaginal or cervical tissue in a larger diameter space immediately after insertion, but may allow the instrument shaft 2133 to continue to be inserted into the uterus if necessary.
[0056] 22 is an isometric view of a collapsible cone-shaped sealer 2222 with stepped ridges 2221 or edges extending around the circumference. The distal ring 2223 may be designed to face towards the uterus. The collapsible cone design allows a seal to form around the distal ring 2223 when an instrument is inserted, and also allows an instrument to be inserted further (distally) if necessary without displacing the sealer 2222.
[0057] 23A-23B show an inverted cup-shaped sealant 2322. The distal ring 2331 faces the uterus and is intended to seal the upper vaginal canal (e.g., resting in the vaginal vault) and seal around the cervical opening. The curved distal end 2333 is capable of holding the vacuum in the uterus. As shown in FIG. 23B, the sealant 2322 may include multiple helical ridges and / or valleys, which may, for example, allow for an easier and more predictable way of folding the sealant 2322. These ridges and valleys may allow the physician to gently remove the instrument without tearing the fresh vaginal sutures. Additionally, these ridges and valleys may aid in the insertion of the instrument, since the sealant 2322 may be pinched and twisted between two fingers to grip, which may improve visibility during placement.
[0058] 24 shows an inverted cup-shaped seal 2422, which is similar to seal 2322, but includes axially extending pleats 2441 to facilitate folding of seal 2422 during insertion. The material used for seal 2422 may be resilient to allow the material to naturally unfold back to its cup shape once the folding force is released (e.g., after insertion).
[0059] FIG. 25 shows a cup-shaped seal 2522, which is similar to seal 2322 except that the distal end 2551 flares outward slightly.
[0060] 26A-26B show sealant 2622, which is similar to sealant 2622, except that it includes a conformable, flared distal end 2661 that can unroll (i.e., roll proximally) on itself (e.g., to accommodate the smaller diameter of the vaginal or cervical canal). FIG. 26A shows end 2661 in a flared position, while FIG. 26B shows end 2661 in a proximally rolled position.
[0061] 27 shows a sealant 2722 that includes a central disk 2771 or diaphragm that supports a curved annular structure 2773. The annular structure 2773 is capable of retaining a vacuum within the uterus by sealing against the vaginal or cervical walls (e.g., at the cervical opening).
[0062] FIG. 28 shows a seal 2822 that includes a curved annular structure 2883 that is attached to and supported by a shaft 2833 at its proximal end and is open at its distal end.
[0063] FIG. 29 illustrates another exemplary sealant 2922. The sealant 2922 includes an inflatable bulb 2937 that seals against the shaft 2977 of an insertable instrument. The bulb 2937 may be made of a material that allows the bulb 2937 to be secured against tissue at the opening of the cervix after delivery. In some embodiments, for example, the bulb 2937 may be made of medium durometer silicone or other flexible material. The bulb 2937 may further include a taper 2939 at the distal end that facilitates insertion through the vaginal canal into the cervix. The overall shape of the bulb 2937 may advantageously provide a seal when a vacuum is drawn into the uterus. In some embodiments, the bulb 2937 may include an annular reinforcing ring 2938 around its periphery. The reinforcing ring may have a greater strength than the rest of the bulb 2937, which helps the bulb 2937 maintain its circular or elliptical shape when pressed against a tissue wall. In some embodiments, the reinforcing ring 2938 may be made of the same material as the rest of the bulb 2937, but may be thicker.
[0064] In some embodiments, the bulb 2937 may be configured to inflate and deflate only with air from the balance chamber 2940. The balance chamber 2940 may be a thin sleeve or balloon made of a very thin, soft durometer material. The balance chamber 2940 may be configured to receive air from the bulb 2937 only when the bulb 2937 is compressed. The size or length of the balance chamber 2940 may be optimized such that the diameter of the balance chamber 2940 is not larger than the bulb 2937 when the bulb 2937 is compressed. A channel between the balance chamber 2940 and the bulb 2937 may allow air to pass back and forth between the balance chamber 2940 and the bulb 2937 as the bulb 2937 returns to its original shape (e.g., after the compression applied during insertion of the instrument is released). Bulb 2937 and balance chamber 2940 are sealed and may advantageously be easy to clean and sterilize if multiple uses are required.
[0065] In another embodiment, bulb 2937 is inflatable via an inflation lumen. In yet another embodiment, bulb 2937 is inflatable by introducing air through a vent or hole in the proximal end of bulb 2937 (e.g., without a balance chamber).
[0066] The systems, devices, and methods described herein can advantageously stop postpartum bleeding by drawing a vacuum in the uterus after delivery to remove blood from the uterus and assist in uterine contractions.
[0067] In some embodiments, at least a portion of the systems and devices described herein may be transparent to allow visualization of blood and fluids being aspirated from the uterus.
[0068] Any of the devices described herein may be used to continuously apply a vacuum within the bleeding uterus for 1-24 hours or less. In some embodiments, the uterus may be kept in an isobaric state by application of the vacuum. In some embodiments, bleeding may cease in less than an hour (e.g., in less than 30 minutes, or in less than 20 minutes, or in less than 5 minutes, or in less than 2 minutes).
[0069] Any of the devices described herein can be used without a separate sealing member, i.e., tissue can seal against the uterus directly around the elongate body or shaft.
[0070] Any of the instruments described herein may include a distal tip having soft, rounded edges to prevent trauma to body tissue during insertion.
[0071] Any of the instruments described herein may have a vacuum hole at its distal tip (e.g., aligned with a centerline through the vacuum lumen and / or aligned with the centerline of two lumens). Such a vacuum hole can advantageously aid in accessing blood and clots near the tip and / or facilitate ease of cleaning (e.g., with a wire brush) to the tip of the instrument.
[0072] Any of the devices described herein may be flexible to conform to local anatomy.
[0073] Any of the devices described herein may be more flexible along a first axis than along a second axis. For example, the device may be more flexible along an axis perpendicular to the coronal plane than along an axis perpendicular to the sagittal plane, which may advantageously help the device to conform to the natural upward angle of the uterus. Alternatively, any of the devices described herein may be equally flexible along an axis perpendicular to the coronal plane as along an axis perpendicular to the sagittal plane, which may allow, for example, the device to be placed within the uterus without regard to orientation.
[0074] It will be appreciated that any feature described herein with respect to one embodiment may be used in place of, or in addition to, any element described herein with respect to another embodiment.
[0075] In this specification, when a feature or element is referred to as being "on" another feature or element, the feature or element may be directly adjacent to the other feature or element, or there may be intervening features and / or elements. In contrast, when a feature or element is referred to as being "directly on" another feature or element, there are no intervening features and / or elements. It should also be understood that when a feature or element is referred to as being "connected," "attached," or "coupled" to another feature or element, the feature or element may be directly connected, attached, or coupled to the other feature or element, or there may be intervening features or elements. In contrast, when a feature or element is referred to as being "directly connected," "directly attached," or "directly coupled" to another feature or element, there are no intervening features or elements. Features and elements so described or illustrated may be described or illustrated with respect to one embodiment, but may also apply to other embodiments. Also, as will be understood by those skilled in the art, when a structure or feature is referred to as being "adjacent" to another feature, the reference may include portions that overlap or underlie the adjacent feature.
[0076] The terms used herein are for the purpose of describing particular embodiments only and are not intended to be limiting of the present invention. For example, the singular forms "a," "an," and "the" as used herein are intended to encompass the plural forms as well, unless the context clearly contradicts otherwise. It is further understood that the terms "comprises" and / or "comprising," as used herein, specify the presence of stated features, steps, operations, elements, and / or components, and do not exclude the presence or addition of one or more other features, steps, operations, elements, components, and / or groups thereof. As used herein, the term "and / or" includes any and all combinations of one or more of the associated listed items and may be abbreviated as " / ."
[0077] Spatially relative terms such as "under," "below," "lower," "over," "upper," and the like may be used herein for ease of description when describing the relationship of one element or feature to another element or feature as depicted in the figures. It should be understood that these spatially relative terms are intended to encompass other orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if the device in the figures were inverted, an element described as being "under" or "beneath" another element or feature would be oriented "over" that other element or feature. Thus, for example, the term "under" may encompass both an orientation of "over" and "under." The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, terms such as "upwardly," "downwardly," "vertical," "horizontal," etc. are used herein for descriptive purposes only, unless otherwise specified.
[0078] The terms "first" and "second" may be used herein to describe various features / elements (including steps), but these features / elements should not be limited by these terms unless the context indicates otherwise. These terms may be used to distinguish one feature / element from another. Thus, a first feature / element may be referred to as a second feature / element below, and similarly, a second feature / element may be referred to as a first feature / element below, without departing from the teachings of the present invention.
[0079] Throughout this specification and the claims that follow, unless otherwise stated, the term "comprise" and its variations "comprises," "comprising," and the like, mean that various components may be used in conjunction with one another in methods and articles (e.g., devices and method-containing compositions and apparatus). For example, the word "comprising" should be understood to imply the inclusion of all stated elements or steps, but not the exclusion of any other elements or steps.
[0080] As used in the specification and claims, including in the examples, and unless otherwise specified, any numerical value may be read as if it is preceded by the word "about" or "approximately", even if the word is not explicitly present. The words "about" or "approximately", when describing a size and / or location, may be used to indicate that the stated value and / or location falls within a reasonable expected range of values and / or locations. For example, a numerical value may be ±0.1% of the stated value (or range of values), ±1% of the stated value (or range of values), ±2% of the stated value (or range of values), ±5% of the stated value (or range of values), ±10% of the stated value (or range of values), or other such values. Any numerical range described herein is intended to encompass all subranges subsumed therein.
[0081] Although various exemplary embodiments have been described above, any of a number of modifications may be made to the various embodiments without departing from the scope of the invention as set forth in the claims. For example, the order in which the various method steps described are performed may often be changed in alternative embodiments, and in some alternative embodiments, one or more method steps may be skipped altogether. Optional features of the various embodiments of the apparatus and systems may be included in some embodiments and not included in other embodiments. Thus, the above description is primarily for illustrative purposes and should not be construed as limiting the scope of the invention as set forth in the claims.
[0082] The examples and specific examples contained herein are illustrative, not limiting, of specific embodiments in which the subject matter may be practiced. As noted, other embodiments may be utilized or derived, and structural or logical substitutions or changes may be made without departing from the scope of the present disclosure. Such embodiments of the subject matter may be referred to individually herein or collectively under the term "the present invention," which is merely for convenience and is not intended to spontaneously limit the scope of the present application to any one invention or inventive concept, even if more than one is actually disclosed. Thus, although specific embodiments have been shown and described herein, the specific embodiments shown may be substituted with any configuration designed to achieve the same purpose. The present disclosure is intended to encompass any adaptations or variations of the various embodiments. Combinations of the above-described embodiments, as well as other embodiments not specifically described herein, will become apparent to those skilled in the art upon review of the above description.
Claims
1. an elongate body configured to be connected to a vacuum source; a flexible loop-shaped portion attached to the elongate body and configured to be placed within a uterus, the flexible loop-shaped portion including a plurality of holes on an inner circumference thereof, and activation of the vacuum source configured to draw a vacuum through the plurality of holes to deflate the uterus when the elongate body is inserted into the uterus; a shield having an edge that folds around an outer periphery of the looped portion and extends radially inward relative to the flexible looped distal portion, the shield configured to prevent tissue from blocking the plurality of holes when a vacuum is applied; an inflatable seal attached to the elongate body and configured to seal against the uterus; Bleeding prevention devices including:
2. The bleeding prevention device of claim 1 , wherein the flexible loop portion is configured to collapse upon delivery and to self-expand into an expanded loop shape.
3. The bleeding prevention device of claim 1 , wherein the shield extends around 270-320 degrees of the circumference of the flexible looped distal portion.
4. 10. The bleeding prevention device of claim 1, wherein said shield extends radially inward a distance of 0.02 to 0.020".
5. The bleeding prevention device of claim 1 , wherein said plurality of holes comprises between 10 and 20 holes.
6. The bleeding prevention device of claim 1 , wherein the sealant has a disk-shaped central portion and tapered proximal and distal ends.
7. The bleeding prevention device of claim 1 , further comprising a valved port in fluid communication with said elongate body, said valved portion configured to supply inflation fluid to said inflatable seal.
8. The bleeding prevention device of claim 7 , wherein the valve comprises a check valve.
9. a first elongated tube having a first central channel; a second elongated tube having a second central channel, the second elongated tube being joined to and parallel to the first elongated tube, thereby forming an axial valley between the first and second elongated tubes; a connector configured to connect the first and second central channels to a vacuum source; and a plurality of holes disposed along the valleys, each of the plurality of holes extending from an outer surface of the device and communicating with both the first central channel and the second central channel, wherein activation of the vacuum source is configured to draw a vacuum through the plurality of holes to deflate the uterus when the device is inserted into the uterus; Bleeding prevention devices including:
10. The bleeding prevention device of claim 9 , wherein each of said plurality of holes has an elongated shape along said valley.
11. The bleeding prevention device of claim 9 , wherein each of said plurality of holes has a circular shape along said valley.
12. The bleeding prevention device of claim 9, further comprising a sealant disposed along said first and second elongated tubes.
13. The bleeding prevention device of claim 12 , wherein the sealant has a disk-shaped central portion and tapered proximal and distal ends.
14. 10. The bleeding prevention device of claim 9, wherein said valleys are 0.02 to 0.2" deep.
15. The bleeding prevention device according to claim 9, wherein the valley angle is between 10 and 80 degrees.
16. 10. The bleeding prevention device of claim 9, wherein the ratio of said device width to said device height is between 1.4 and 2.3, said width and height being perpendicular to said axial valley.
17. 10. The bleeding prevention device of claim 9, wherein the ratio of said device height to said device width is between 1.4 and 2.3, said width and height perpendicular to said axial valley.
18. 10. The bleeding prevention device of claim 9, wherein the ratio of said device height to said device width is about 1, said width and height being perpendicular to said axial valley.
19. The bleeding prevention device of claim 9 , wherein each of said plurality of holes extends completely through said valley from said outer surface to an opposite second outer surface.
20. The bleeding prevention device of claim 9 further comprising a tapered distal tip.
21. an elongate body configured to be connected to a vacuum source, the elongate body having a plurality of holes, and activation of the vacuum source configured to draw a vacuum through the plurality of holes to deflate the uterus when the elongate body is inserted into the uterus; a sealant attached to the elongate body and configured to seal the uterus, the sealant including a proximal ring and a distal skirt and configured to have a generally conical shape; and Bleeding prevention devices including:
22. 22. The bleeding prevention device of claim 21, wherein the sealant is proximal to the hole.
23. The bleeding prevention device of claim 21, wherein the angle of the skirt relative to the elongate body is between 30 and 60 degrees.
24. A bleeding prevention device according to claim 21, wherein said ring has a diameter of between 2 and 10 mm.
25. 22. The bleeding prevention device of claim 21, wherein said ring is stiffer than said skirt.
26. 22. The bleeding prevention device of claim 21, wherein the ring is thicker than the skirt.
27. A bleeding prevention device according to claim 21, wherein the skirt has a thickness of 1 to 1.5 mm.
28. 22. The bleeding prevention device of claim 21, wherein the ring lies in a plane generally perpendicular to a longitudinal axis of the elongate body.
29. 22. The bleeding prevention device of claim 21, wherein the proximal ring is configured to press against tissue of the vaginal canal or cervical wall.
30. 22. The bleeding prevention device of claim 21, wherein the seal is configured to invert when the elongate body is pulled in a proximal direction.
31. 31. The bleeding prevention device of claim 30, wherein the skirt is contiguous with an outermost diameter portion of the proximal ring when the seal is inverted.
32. 22. The bleeding prevention device of claim 21, wherein the skirt has a varying thickness from its proximal end to its distal end.
33. 22. The bleeding prevention device of claim 21, wherein the skirt has a uniform thickness from its proximal end to its distal end.
Citation Information
Patent Citations
Uterine bleeding control system and method
JP2015512275A
Uterine hemorrhage controlling system and method
US20180055523A1
